MedPath

Laurus Generics Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$2.9B
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

FDA:2

Drug Approvals

Ranolazine

Approval Date
Mar 23, 2022
FDA

Levetiracetam

Approval Date
Sep 13, 2021
FDA

Clinical Trials

No trials found

News

Indian CRDMOs Gain Momentum as Global Pharma Diversifies Manufacturing Operations

Indian Contract Research and Development and Manufacturing Organizations (CRDMOs) are attracting increased attention from global pharmaceutical companies as Big Pharma pursues geographic diversification strategies.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.